--- title: "16:01 ETCharming Medical Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MCTA" description: "Charming Medical Limited (NASDAQ: MCTA) is facing a class action lawsuit for securities law violations, specifically for making false and misleading statements, as per the DJS Law Group. The lawsuit p" type: "news" locale: "en" url: "https://longbridge.com/en/news/275360935.md" published_at: "2026-02-09T21:02:16.000Z" --- # 16:01 ETCharming Medical Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MCTA > Charming Medical Limited (NASDAQ: MCTA) is facing a class action lawsuit for securities law violations, specifically for making false and misleading statements, as per the DJS Law Group. The lawsuit pertains to the period from October 21, 2025, to November 12, 2025, with a deadline for lead plaintiff appointments set for February 17, 2026. The SEC has suspended trading of Charming shares due to an investigation into alleged schemes to artificially inflate share prices. Shareholders who incurred losses are encouraged to participate in the lawsuit. , /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Charming Medical Limited ("Charming " or "the Company") (NASDAQ: MCTA ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of MCTA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery. **CLASS PERIOD:** October 21, 2025 to November 12, 2025 **DEADLINE:** February 17, 2026 **CASE DETAILS:** According to the Complaint, the Company made false and misleading statements to the market. The SEC suspended the trading of Charming shares based on the investigation of an alleged scheme to boost the Company's share price by supposed financial advisors touting shares on social media. Based on these facts, Charming's public statements were false and materially misleading throughout the class period. If you are a shareholder who suffered a loss, contact us to participate. **WHY DJS LAW GROUP?** DJS Law Group's primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results. Join the case to recover your losses. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics. **CONTACT:** David J. Schwartz DJS Law Group 274 White Plains Road, Suite 1 Eastchester, NY 10709 Phone: 914-206-9742 Email: \[email protected\] SOURCE DJS Law Group LLP ### Related Stocks - [MCTA.US - Charming Medical](https://longbridge.com/en/quote/MCTA.US.md) - [IXJ.US - iShares Global Healthcare](https://longbridge.com/en/quote/IXJ.US.md) - [XLV.US - Health Care Select Sector SPDR](https://longbridge.com/en/quote/XLV.US.md) - [IHF.US - iShares US Healthcare Providers](https://longbridge.com/en/quote/IHF.US.md) - [VHT.US - VG Health](https://longbridge.com/en/quote/VHT.US.md) - [XHS.US - SPDR S&P Health](https://longbridge.com/en/quote/XHS.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | Amwill Health Care 的网络安全事件影响了 2025 年 9 月的账户数据 | Amwill Health Care Ltd：AMWILL HEALTH CARE LTD - 网络安全事件影响了 2025 年 9 月的账户数据，AMWILL HEALTH CARE - 受影响的系统已被隔离，调查正在进行中 | [Link](https://longbridge.com/en/news/276242188.md) | | 在乐观的第四季度收益报告后，Kenvue 的分析师上调了他们的预测 | Kenvue Inc（纽约证券交易所代码：KVUE）公布了强劲的第四季度财报，每股收益为 27 美分，超过了 22 美分的预期，销售额为 37.8 亿美元，超出 36.81 亿美元的预测。首席执行官 Kirk Perry 强调了严格的执行和 | [Link](https://longbridge.com/en/news/276259878.md) | | 未来展望：15 位分析师对休曼纳的预测 | 在最新的季度中，15 位分析师对 Humana（纽约证券交易所代码：HUM）给出了混合评级，平均 12 个月目标价为 221.8 美元，反映出 19.14% 的下降。主要分析师下调了他们的评级，其中 Wells Fargo 和 Goldma | [Link](https://longbridge.com/en/news/276258083.md) | | 社区卫生系统第四季度的收入略低于分析师的预期 | 社区卫生系统第四季度的收入略低于分析师预期，报告为 31.1 亿美元，而市场共识为 31.4 亿美元。调整后的息税折旧摊销前利润（EBITDA）也未达到预期，录得 3.95 亿美元，预期为 3.9569 亿美元。入院人数下降 6.6% 对收 | [Link](https://longbridge.com/en/news/276273944.md) | | Mondrian Investment Partners LTD 购入了 250,130 股 HCA Healthcare, Inc.（$HCA）的股票 | 蒙德里安投资伙伴有限公司收购了 250,130 股 HCA Healthcare, Inc.，交易金额约为 1.066 亿美元，占其持股的 1.8%。包括挪威银行和 Pacer Advisors Inc.在内的其他投资者也增加了对 HCA | [Link](https://longbridge.com/en/news/276118088.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.